IdeS in anti-glomerular basement membrane disease: Is this the new deal?
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 31648697.
- Also identified by DOI 10.1016/j.kint.2019.08.017.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
IdeS, a proteinase from Streptococcus pyogenes, cleaves IgG antibodies with a unique specificity. Herein, the authors report the dramatic efficacy of IdeS on the levels of anti-glomerular membrane autoantibodies in 3 three patients with Goodpasture disease refractory to standard therapy. The levels of anti-glomerular membrane autoantibodies were reduced to near-zero levels within 2 hours of the injection. However, all patients ultimately required permanent hemodialysis as a result of the late intervention in the course of the disease.
Medical subject headings
- Anti-Glomerular Basement Membrane Disease